Plamumab 40mg Adalimumab Injection

Plamumab 40mg Adalimumab Injection is a prescription biologic medication used to manage a range of autoimmune and inflammatory disorders, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa. It contains Adalimumab, a monoclonal antibody that targets and blocks tumor necrosis factor-alpha (TNF-α), a protein responsible for promoting inflammation in the body. By reducing inflammatory activity, Plamumab 40mg Adalimumab Injection helps relieve symptoms, improve physical function, and support long-term disease management. Administered as a subcutaneous injection under medical supervision, it requires regular monitoring to assess treatment response and ensure patient safety. Patients should use Plamumab 40mg Injection only according to their healthcare provider’s instructions.